A detailed history of Spear Holdings Rsc LTD transactions in Crispr Therapeutics Ag stock. As of the latest transaction made, Spear Holdings Rsc LTD holds 165,000 shares of CRSP stock, worth $8.22 Million. This represents 7.77% of its overall portfolio holdings.

Number of Shares
165,000
Previous 165,000 -0.0%
Holding current value
$8.22 Million
Previous $8.91 Billion 13.02%
% of portfolio
7.77%
Previous 6.29%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$60.67 - $89.12 $10 Million - $14.7 Million
165,000 New
165,000 $11.2 Billion

Others Institutions Holding CRSP

About CRISPR Therapeutics AG


  • Ticker CRSP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 78,009,296
  • Market Cap $3.88B
  • Description
  • CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....
More about CRSP
Track This Portfolio

Track Spear Holdings Rsc LTD Portfolio

Follow Spear Holdings Rsc LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Spear Holdings Rsc LTD, based on Form 13F filings with the SEC.

News

Stay updated on Spear Holdings Rsc LTD with notifications on news.